Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


Articles published in Virology

Retrieve available abstracts of 58 articles:
HTML format
Text format



Single Articles


    March 2017
  1. ZAPATA JC, Campilongo F, Barclay RA, DeMarino C, et al
    The Human Immunodeficiency Virus 1 ASP RNA promotes viral latency by recruiting the Polycomb Repressor Complex 2 and promoting nucleosome assembly.
    Virology. 2017;506:34-44.
    PubMed     Text format     Abstract available


  2. CROOKS ET, Osawa K, Tong T, Grimley SL, et al
    Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction.
    Virology. 2017;505:193-209.
    PubMed     Text format     Abstract available


    February 2017
  3. BANERJEE S, Shi H, Banasik M, Moon H, et al
    Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region.
    Virology. 2017;505:113-126.
    PubMed     Text format     Abstract available


  4. BONAR MM, Tilton JC
    High sensitivity detection and sorting of infectious human immunodeficiency virus (HIV-1) particles by flow virometry.
    Virology. 2017;505:80-90.
    PubMed     Text format     Abstract available


  5. RODGERS MA, Vallari AS, Harris B, Yamaguchi J, et al
    Identification of rare HIV-1 Group N, HBV AE, and HTLV-3 strains in rural South Cameroon.
    Virology. 2017;504:141-151.
    PubMed     Text format     Abstract available


    January 2017
  6. ROBINSON TO, Zhang M, Ochsenbauer C, Smythies LE, et al
    CD4 regulatory T cells augment HIV-1 expression of polarized M1 and M2 monocyte derived macrophages.
    Virology. 2017;504:79-87.
    PubMed     Text format     Abstract available


  7. GEDDES VE, Jose DP, Leal FE, Nixon DF, et al
    HTLV-1 Tax activates HIV-1 transcription in latency models.
    Virology. 2017;504:45-51.
    PubMed     Text format     Abstract available


  8. FILIPPONE C, de Oliveira F, Betsem E, Schaeffer L, et al
    Simian Immunodeficiency Virus seroreactivity in inhabitants from rural Cameroon frequently in contact with non-human primates.
    Virology. 2017;503:76-82.
    PubMed     Text format     Abstract available


  9. MIYAGI E, Kao S, Fumitaka M, Buckler-White A, et al
    Long-term passage of Vif-null HIV-1 in CD4+ T cells expressing sub-lethal levels of APOBEC proteins fails to develop APOBEC resistance.
    Virology. 2017;504:1-11.
    PubMed     Text format     Abstract available


  10. ZHAO G, Wu G, Lim ES, Droit L, et al
    VirusSeeker, a computational pipeline for virus discovery and virome composition analysis.
    Virology. 2017;503:21-30.
    PubMed     Text format     Abstract available


    December 2016
  11. YUAN Z, Ma F, Demers AJ, Wang D, et al
    Characterization of founder viruses in very early SIV rectal transmission.
    Virology. 2016;502:97-105.
    PubMed     Text format     Abstract available


  12. LE SAGE V, Cinti A, McCarthy S, Amorim R, et al
    Ebola virus VP35 blocks stress granule assembly.
    Virology. 2016;502:73-83.
    PubMed     Text format     Abstract available


    November 2016
  13. HU S, Neff CP, Kumar DM, Habu Y, et al
    A humanized mouse model for HIV-2 infection and efficacy testing of a single-pill triple-drug combination anti-retroviral therapy.
    Virology. 2016;501:115-118.
    PubMed     Text format     Abstract available


  14. VANWALSCAPPEL B, Rato S, Perez-Olmeda M, Diez Fuertes F, et al
    Genetic and phenotypic analyses of sequential vpu alleles from HIV-infected IFN-treated patients.
    Virology. 2016;500:247-258.
    PubMed     Text format     Abstract available


  15. MOYO T, Ferreira RC, Davids R, Sonday Z, et al
    Chinks in the armor of the HIV-1 Envelope glycan shield: Implications for immune escape from anti-glycan broadly neutralizing antibodies.
    Virology. 2016;501:12-24.
    PubMed     Text format     Abstract available


  16. LAMICHHANE R, Mukherjee S, Smolin N, Pauszek RF 3rd, et al
    Dynamic conformational changes in the rhesus TRIM5alpha dimer dictate the potency of HIV-1 restriction.
    Virology. 2016;500:161-168.
    PubMed     Text format     Abstract available


    October 2016
  17. ASMAL M, Lane S, Tian M, Nickel G, et al
    Pathogenic infection of Rhesus macaques by an evolving SIV-HIV derived from CCR5-using envelope genes of acute HIV-1 infections.
    Virology. 2016;499:298-312.
    PubMed     Text format     Abstract available


    September 2016
  18. MAKHDOOMI MA, Singh D, Nair Pananghat A, Lodha R, et al
    Neutralization resistant HIV-1 primary isolates from antiretroviral naive chronically infected children in India.
    Virology. 2016;499:105-113.
    PubMed     Text format     Abstract available


  19. AGOSTO LM, Hirnet JB, Michaels DH, Shaik-Dasthagirisaheb YB, et al
    Porphyromonas gingivalis-mediated signaling through TLR4 mediates persistent HIV infection of primary macrophages.
    Virology. 2016;499:72-81.
    PubMed     Text format     Abstract available


  20. SUGDEN S, Ghazawi F, MacPherson P
    HIV-1 tat protein recruits CIS to the cytoplasmic tail of CD127 to induce receptor ubiquitination and proteasomal degradation.
    Virology. 2016;498:192-200.
    PubMed     Text format     Abstract available


    August 2016
  21. WANG Y, Wang Z, Pramanik A, Santiago ML, et al
    A chimeric human APOBEC3A protein with a three amino acid insertion confers differential HIV-1 and adeno-associated virus restriction.
    Virology. 2016;498:149-163.
    PubMed     Text format     Abstract available


  22. IMLE A, Stolp B, Bohmer V, Geyer M, et al
    D186/D190 is an allele-dependent determinant of HIV-1 Nef function.
    Virology. 2016;498:44-56.
    PubMed     Text format     Abstract available


  23. KIJEWSKI SD, Akiyama H, Feizpour A, Miller CM, et al
    Access of HIV-2 to CD169-dependent dendritic cell-mediated trans infection pathway is attenuated.
    Virology. 2016;497:328-336.
    PubMed     Text format     Abstract available


    July 2016
  24. ALEXANDRE KB, Mufhandu HT, London GM, Chakauya E, et al
    Progress and Perspectives on HIV-1 microbicide development.
    Virology. 2016;497:69-80.
    PubMed     Text format     Abstract available


  25. SANTOS S, Obukhov Y, Nekhai S, Pushkarsky T, et al
    Cellular minichromosome maintenance complex component 5 (MCM5) is incorporated into HIV-1 virions and modulates viral replication in the newly infected cells.
    Virology. 2016;497:11-22.
    PubMed     Text format     Abstract available


    June 2016
  26. ZHANG X, Zhou T, Frabutt DA, Zheng YH, et al
    HIV-1 Vpr increases Env expression by preventing Env from endoplasmic reticulum-associated protein degradation (ERAD).
    Virology. 2016;496:194-202.
    PubMed     Text format     Abstract available


  27. KAKISAKA M, Yamada K, Yamaji-Hasegawa A, Kobayashi T, et al
    Intrinsically disordered region of influenza A NP regulates viral genome packaging via interactions with viral RNA and host PI(4,5)P.
    Virology. 2016;496:116-126.
    PubMed     Text format     Abstract available


    May 2016
  28. JUNQUEIRA DM, Almeida SE
    HIV-1 subtype B: Traces of a pandemic.
    Virology. 2016;495:173-184.
    PubMed     Text format     Abstract available


  29. LIN YZ, Sun LK, Zhu DT, Hu Z, et al
    Equine schlafen 11 restricts the production of equine infectious anemia virus via a codon usage-dependent mechanism.
    Virology. 2016;495:112-121.
    PubMed     Text format     Abstract available


  30. BONIFATI S, Daly MB, St Gelais C, Kim SH, et al
    SAMHD1 controls cell cycle status, apoptosis and HIV-1 infection in monocytic THP-1 cells.
    Virology. 2016;495:92-100.
    PubMed     Text format     Abstract available


    April 2016
  31. ZHANG J, Gao X, Martin J, Rosa B, et al
    Evolution of coreceptor utilization to escape CCR5 antagonist therapy.
    Virology. 2016;494:198-214.
    PubMed     Text format     Abstract available


  32. BURGER-CALDERON R, Ramsey KJ, Dolittle-Hall JM, Seaman WT, et al
    Distinct BK polyomavirus non-coding control region (NCCR) variants in oral fluids of HIV- associated Salivary Gland Disease patients.
    Virology. 2016;493:255-266.
    PubMed     Text format     Abstract available


  33. KRIEK JM, Jaumdally SZ, Masson L, Little F, et al
    Female genital tract inflammation, HIV co-infection and persistent mucosal Human Papillomavirus (HPV) infections.
    Virology. 2016;493:247-254.
    PubMed     Text format     Abstract available


  34. SIQUEIRA JD, Alves BM, Prellwitz IM, Furtado C, et al
    Identification of novel human papillomavirus lineages and sublineages in HIV/HPV-coinfected pregnant women by next-generation sequencing.
    Virology. 2016;493:202-208.
    PubMed     Text format     Abstract available


    March 2016
  35. GARG H, Lee RT, Maurer-Stroh S, Joshi A, et al
    HIV-1 adaptation to low levels of CCR5 results in V3 and V2 loop changes that increase envelope pathogenicity, CCR5 affinity and decrease susceptibility to Maraviroc.
    Virology. 2016;493:86-99.
    PubMed     Text format     Abstract available


  36. LIANG Z, Liu R, Zhang H, Zhang S, et al
    GADD45 proteins inhibit HIV-1 replication through specific suppression of HIV-1 transcription.
    Virology. 2016;493:1-11.
    PubMed     Text format     Abstract available


  37. FERNS RB, Tarr AW, Hue S, Urbanowicz RA, et al
    Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals.
    Virology. 2016;492:213-224.
    PubMed     Text format     Abstract available


  38. YU KL, Lee SH, Lee ES, You JC, et al
    HIV-1 nucleocapsid protein localizes efficiently to the nucleus and nucleolus.
    Virology. 2016;492:204-212.
    PubMed     Text format     Abstract available


    February 2016
  39. LLOYD SB, Lichtfuss M, Amarasena TH, Alcantara S, et al
    High fidelity simian immunodeficiency virus reverse transcriptase mutants have impaired replication in vitro and in vivo.
    Virology. 2016;492:1-10.
    PubMed     Text format     Abstract available


  40. HOLLENBAUGH JA, Montero C, Schinazi RF, Munger J, et al
    Metabolic profiling during HIV-1 and HIV-2 infection of primary human monocyte-derived macrophages.
    Virology. 2016;491:106-114.
    PubMed     Text format     Abstract available


  41. DUAN L, Du J, Wang X, Zhou J, et al
    Structural and functional characterization of EIAV gp45 fusion peptide proximal region and asparagine-rich layer.
    Virology. 2016;491:64-72.
    PubMed     Text format     Abstract available


    January 2016
  42. JOHNSON RF, Bagci U, Keith L, Tang X, et al
    3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012.
    Virology. 2016;490:49-58.
    PubMed     Text format     Abstract available


  43. BANERJEE S, Shi H, Habte HH, Qin Y, et al
    Modulating immunogenic properties of HIV-1 gp41 membrane-proximal external region by destabilizing six-helix bundle structure.
    Virology. 2016;490:17-26.
    PubMed     Text format     Abstract available


  44. ESPOSITO AM, Cheung P, Swartz TH, Li H, et al
    A high throughput Cre-lox activated viral membrane fusion assay identifies pharmacological inhibitors of HIV entry.
    Virology. 2016;490:6-16.
    PubMed     Text format     Abstract available


  45. DEBOER J, Madson CJ, Belshan M
    Cyclophilin B enhances HIV-1 infection.
    Virology. 2016;489:282-291.
    PubMed     Text format     Abstract available


  46. VESELINOVIC M, Yang KH, Sykes C, Remling-Mulder L, et al
    Mucosal tissue pharmacokinetics of the integrase inhibitor raltegravir in a humanized mouse model: Implications for HIV pre-exposure prophylaxis.
    Virology. 2016;489:173-178.
    PubMed     Text format     Abstract available


  47. VZOROV AN, Wang L, Chen J, Wang BZ, et al
    Effects of modification of the HIV-1 Env cytoplasmic tail on immunogenicity of VLP vaccines.
    Virology. 2016;489:141-150.
    PubMed     Text format     Abstract available


    December 2015
  48. GABRIEL B, Fiebig U, Hohn O, Plesker R, et al
    Suppressing active replication of a live attenuated simian immunodeficiency virus vaccine does not abrogate protection from challenge.
    Virology. 2015;489:1-11.
    PubMed     Text format     Abstract available


  49. WELBOURN S, Strebel K
    Low dNTP levels are necessary but may not be sufficient for lentiviral restriction by SAMHD1.
    Virology. 2015;488:271-277.
    PubMed     Text format     Abstract available


    November 2015
  50. VAN DER VELDEN YU, Kleibeuker W, Harwig A, Klaver B, et al
    Construction of Nef-positive doxycycline-dependent HIV-1 variants using bicistronic expression elements.
    Virology. 2015;488:96-107.
    PubMed     Text format     Abstract available


  51. DIS ES, Moore TC, Lavender KJ, Messer RJ, et al
    No SEVI-mediated enhancement of rectal HIV-1 transmission of HIV-1 in two humanized mouse cohorts.
    Virology. 2015;488:88-95.
    PubMed     Text format     Abstract available


  52. BAHR A, Singer A, Hain A, Vasudevan AA, et al
    Interferon but not MxB inhibits foamy retroviruses.
    Virology. 2015;488:51-60.
    PubMed     Text format     Abstract available


  53. STAKE M, Singh D, Singh G, Marcela Hernandez J, et al
    HIV-1 and two avian retroviral 5' untranslated regions bind orthologous human and chicken RNA binding proteins.
    Virology. 2015;486:307-320.
    PubMed     Text format     Abstract available


  54. SHINYA E, Shimizu M, Owaki A, Paoletti S, et al
    Hemopoietic cell kinase (Hck) and p21-activated kinase 2 (PAK2) are involved in the down-regulation of CD1a lipid antigen presentation by HIV-1 Nef in dendritic cells.
    Virology. 2015;487:285-295.
    PubMed     Text format     Abstract available


  55. WANG F, St Gelais C, de Silva S, Zhang H, et al
    Phosphorylation of mouse SAMHD1 regulates its restriction of human immunodeficiency virus type 1 infection, but not murine leukemia virus infection.
    Virology. 2015;487:273-284.
    PubMed     Text format     Abstract available


  56. ZHANG HL, Liu FL, Jin YB, Deng Q, et al
    The effects of TRIM5alpha polymorphism on HIV-2ROD and SIVmac239 replication in PBMCs from Chinese rhesus macaques and Vietnamese-origin cynomolgus macaques.
    Virology. 2015;487:222-229.
    PubMed     Text format     Abstract available


  57. HERRERA R, Morris M, Rosbe K, Feng Z, et al
    Human beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cells.
    Virology. 2015;487:172-187.
    PubMed     Text format     Abstract available


    October 2015
  58. KRAMER P, Lausch V, Volkwein A, Hanke K, et al
    The human endogenous retrovirus K(HML-2) has a broad envelope-mediated cellular tropism and is prone to inhibition at a post-entry, pre-integration step.
    Virology. 2015;487:121-128.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: